News Curated Â鶹´«Ã½ Channel: NIH Clinical Center (CC) /articles/channels/NIH Clinical Center (CC) This feature channel highlights experts, research, and feature stories related to NIH Clinical Center (CC) en-us Copyright 2025 News News Curated Â鶹´«Ã½ Channel: NIH Clinical Center (CC) 115 31 / /images/newswise-logo-rss.gif Roswell Park Team Identifies Factors That Boost Effectiveness of Immunotherapy in Recurrent Ovarian Cancer /articles/roswell-park-team-identifies-factors-that-boost-effectiveness-of-immunotherapy-in-recurrent-ovarian-cancer/?sc=c6529 /articles/roswell-park-team-identifies-factors-that-boost-effectiveness-of-immunotherapy-in-recurrent-ovarian-cancer/?sc=c6529 Thu, 12 Dec 2024 20:35:58 EST All Journal Â鶹´«Ã½,Biotech,Cancer,Healthcare,Microbiome,Women's Health,Grant Funded Â鶹´«Ã½,Nature (journal),NIH Clinical Center (CC),Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/12/12/675b3486269aa_ZsirosEmese090222047Edit.jpg&width=100&height=150" alt="Â鶹´«Ã½ image" />A study led by Roswell Park provides new insight into the complex interactions of the "tumor-immune-gut axis," and its role in influencing immunotherapy responses in patients with recurrent ovarian cancer. Newly published in Nature Communications, the findings emphasize the role of the patient's microbiome -- the collection of microorganisms in the body --and lay the groundwork for future clinical trials aimed at improving treatment outcomes. /articles//images/uploads/2024/12/12/675b3486269aa_ZsirosEmese090222047Edit.jpg Roswell Park Comprehensive Cancer Center